Response Assessment in Neuro-Oncology Criteria and Clinical Endpoints

被引：26
作者：
Huang, Raymond Y. [1 ]
Wen, Patrick Y. [2 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Div Neuroradiol, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med, Brigham & Womens Hosp, Dana Farber Brigham & Womens Canc Ctr, Ctr Neurooncol,Dept Neurol,Div Neurooncol, Boston, MA 02215 USA
来源：
MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA | 2016年 / 24卷 / 04期
关键词：
RANO; Response assessment; Endpoints; Gliomas; Brain metastases; APPARENT DIFFUSION-COEFFICIENT; MAGNETIC-RESONANCE-SPECTROSCOPY; PROTON MR SPECTROSCOPY; CEREBRAL BLOOD-VOLUME; ACRIN; 6677/RTOG; 0625; HIGH-GRADE GLIOMAS; PHASE-II TRIAL; BEVACIZUMAB PLUS IRINOTECAN; SINGLE-AGENT BEVACIZUMAB; TUMOR BRAIN METASTASES;
D O I：
10.1016/j.mric.2016.06.003
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
The Response Assessment in Neuro-Oncology (RANO) Working Group is an international multidisciplinary group whose goal is to improve response criteria and define endpoints for neuro-oncology trials. The RANO criteria for high-grade gliomas attempt to address the issues of pseudoprogression, pseudoresponse, and nonenhancing tumor progression. Incorporation of advanced MR imaging may eventually help improve the ability of these criteria to better define enhancing and nonenhancing disease. The RANO group has also developed criteria for neurologic response and evaluation of patients receiving immunologic therapies. RANO criteria have been developed for brain metastases and are in progress for meningiomas, leptomeningeal disease, spinal tumors, and pediatric tumors.
引用
收藏
页码：705 / +
页数：15
相关论文
共 114 条
[1]   Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations [J].
不详 .
NEOPLASIA, 2009, 11 (02) :102-125
[2]   Retrospective Analysis of Bevacizumab in Combination with Ifosfamide, Carboplatin, and Etoposide in Patients with Second Recurrence of Glioblastoma [J].
Arakawa, Yoshiki ;
Mizowaki, Takashi ;
Murata, Daiki ;
Fujimoto, Koichi ;
Kikuchi, Takayuki ;
Kunieda, Takeharu ;
Takahashi, Jun C. ;
Takagi, Yasushi ;
Miyamoto, Susumu .
NEUROLOGIA MEDICO-CHIRURGICA, 2013, 53 (11) :779-785
[3]   Differentiation between vasogenic-edema versus tumor-infiltrative area in patients with glioblastoma during bevacizumab therapy: A longitudinal MRI study [J].
Artzi, Moran ;
Bokstein, Felix ;
Blumenthal, Deborah T. ;
Aizenstein, Orna ;
Liberman, Gilad ;
Corn, Benjamin W. ;
Ben Bashat, Dafna .
EUROPEAN JOURNAL OF RADIOLOGY, 2014, 83 (07) :1250-1256
[4]  
Asao C, 2005, AM J NEURORADIOL, V26, P1455
[5]   Percent Change of Perfusion Skewness and Kurtosis: A Potential Imaging Biomarker for Early Treatment Response in Patients with Newly Diagnosed Glioblastomas [J].
Baek, Hye Jin ;
Kim, Ho Sung ;
Kim, Namkug ;
Choi, Young Jun ;
Kim, Young Joong .
RADIOLOGY, 2012, 264 (03) :834-843
[6]   Sunitinib administered prior to radiotherapy in patients with non-resectable glioblastoma: results of a Phase II study [J].
Balana, Carmen ;
Gil, Miguel J. ;
Perez, Pedro ;
Reynes, Gaspar ;
Gallego, Oscar ;
Ribalta, Teresa ;
Capellades, Jaume ;
Gonzalez, Sofia ;
Verger, Eugenia .
TARGETED ONCOLOGY, 2014, 9 (04) :321-329
[7]   Differentiation of Recurrent Glioblastoma Multiforme from Radiation Necrosis after External Beam Radiation Therapy with Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging [J].
Barajas, Ramon F., Jr. ;
Chang, Jamie S. ;
Segal, Mark R. ;
Parsa, Andrew T. ;
McDermott, Michael W. ;
Berger, Mitchel S. ;
Cha, Soonmee .
RADIOLOGY, 2009, 253 (02) :486-496
[8]   AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients [J].
Batchelor, Tracy T. ;
Sorensen, A. Gregory ;
di Tomaso, Emmanuelle ;
Zhang, Wei-Ting ;
Duda, Dan G. ;
Cohen, Kenneth S. ;
Kozak, Kevin R. ;
Cahill, Daniel P. ;
Chen, Poe-Jou ;
Zhu, Mingwang ;
Ancukiewicz, Marek ;
Mrugala, Maciej M. ;
Plotkin, Scott ;
Drappatz, Jan ;
Louis, David N. ;
Ivy, Percy ;
Scadden, David T. ;
Benner, Thomas ;
Loeffler, Jay S. ;
Wen, Patrick Y. ;
Jain, Rakesh K. .
CANCER CELL, 2007, 11 (01) :83-95
[9]   Distinguishing Recurrent High-grade Gliomas from Radiation Injury: A Pilot Study Using Dynamic Contrast-enhanced MR Imaging [J].
Bisdas, Sotirios ;
Naegele, Thomas ;
Ritz, Rainer ;
Dimostheni, Artemisia ;
Pfannenberg, Christina ;
Reimold, Matthias ;
Koh, Tong San ;
Ernemann, Ulrike .
ACADEMIC RADIOLOGY, 2011, 18 (05) :575-583
[10]   Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader Study [J].
Boxerman, Jerrold L. ;
Zhang, Zheng ;
Safriel, Yair ;
Larvie, Mykol ;
Snyder, Bradley S. ;
Jain, Rajan ;
Chi, T. Linda ;
Sorensen, A. Gregory ;
Gilbert, Mark R. ;
Barboriak, Daniel P. .
NEURO-ONCOLOGY, 2013, 15 (07) :945-954
12345678910